Clincosm LogoSign in Get a demo

Microarray Analysis of Gene Expression in Liver Tumors

Sponsor
Stanford University (Other)
Overall Status
Completed
CT.gov ID
NCT00373737
Collaborator
National Institutes of Health (NIH) (NIH)
300
Enrollment
1
Location
115.1
Duration (Months)
2.6
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This study aims to study the gene expression profiles of liver tumors to help us understand their biology, and to find new tumor and treatment markers for liver cancer.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The purpose of this research is to study of the biologic features of liver tissue (by studying their gene expression profiles), so that we can increase our understanding of the processes involved in liver cancer development and growth. This may allow us to identify more effective ways of diagnosing, treating, and predicting the outcome of patients with liver cancer.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    300 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Microarray Analysis of Gene Expression in Liver Tumors
    Study Start Date :
    May 1, 1999
    Actual Primary Completion Date :
    Apr 1, 2008
    Actual Study Completion Date :
    Dec 1, 2008

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion Criteria:Inclusion Criteria:

      • Patients with liver tumors undergoing partial liver resection, open liver biopsy, and patients undergoing liver transplantation with or without liver tumors at Stanford University

      • Patients older than 18

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Stanford University School of Medicine Stanford California United States 94305

      Sponsors and Collaborators

      • Stanford University
      • National Institutes of Health (NIH)

      Investigators

      • Principal Investigator: Samuel So, Stanford University

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT00373737
      Other Study ID Numbers:
      • HEP0005
      • 76710
      • HEP0005
      First Posted:
      Sep 8, 2006
      Last Update Posted:
      Jul 27, 2010
      Last Verified:
      Jul 1, 2010
      Additional relevant MeSH terms:
      Liver Neoplasms

      Study Results

      No Results Posted as of Jul 27, 2010